Hypertension Clinical Trial
Official title:
Evaluation of Home Blood Pressure Measurement for the Management of Hypertension in Treated Hypertensive Patients
Verified date | July 2021 |
Source | DongGuk University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Home blood pressure measurement has been reported to be associated with better clinic blood pressure and daytime blood pressure control. However, no study has evaluated the association between home blood pressure measurement and control of 24-hour ambulatory blood pressure in real world practice. The purpose of the present study is to investigate the effect of home blood pressure measurement on the control of ambulatory blood pressure in the real world. The detailed purposes of the present study are (1) to investigate the effects of home blood pressure measurement on the appropriate control of 24-hour ambulatory blood pressure in hypertensive patients treated with antihypertensive drug, (2) to evaluate the effect of home blood pressure measurement on the occurrence of cardiovascular events and target organ damage, (3) to investigate the status and appropriateness of home blood pressure measurement in the real world, and (4) to investigate factors of home blood pressure measurement methods affecting the treatment of hypertension.
Status | Active, not recruiting |
Enrollment | 701 |
Est. completion date | December 31, 2026 |
Est. primary completion date | May 13, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - Patients with hypertension and taking antihypertensive drugs more than 1 year Exclusion Criteria: - Secondary hypertension - Hypertensive emergency and urgency - Severe heart failure (NYHA III and IV) - Angina with 6 months - Myocardial infarction within 6 months - Peripheral artery disease within 6 months - Significant arrhythmia (i.e. ventricular tachycardia and fibrillation, atrial fibrillation, atrial flutter) - Pregnancy - Night labor, shift worker - Those who are currently participating in other clinical studies - Those who have taken other clinical trial drugs within the past month - According to the opinion of the researcher, those who have or may have a disease that may interfere with the completion of the study - History of drug or alcohol dependence within 6 months |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Dongguk University Ilsan Hospital | Goyang | Gyeonggi |
Lead Sponsor | Collaborator |
---|---|
DongGuk University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference of 24-hour blood pressure control rate | difference of 24-hour blood pressure control rate between patients who measure and do not measure home blood pressure | at baseline and 3 years of follow up | |
Secondary | Difference of daytime blood pressure control rate | Difference of daytime blood pressure control rate between patients who measure and do not measure home blood pressure | at baseline and 3 years of follow up | |
Secondary | Difference of office blood pressure control rate | Difference of office blood pressure control rate between patients who measure and do not measure home blood pressure | at baseline and 3 years of follow up | |
Secondary | Difference of systolic and diastolic blood pressure (office, 24-hour, daytime, nighttime) | Difference of systolic and diastolic blood pressure (office, 24-hour, daytime, nighttime) between patients who measure and do not measure home blood pressure | at baseline and 3 years of follow up | |
Secondary | Rate of home blood pressure measurement | Rate of home blood pressure measurement in study population | at baseline and 3 years of follow up | |
Secondary | Reflection of home blood pressure | Rate of reflecting home blood pressure in the treatment of hypertension at office | at baseline and 3 years of follow up | |
Secondary | cardiovascular disease prevalence and target organ damage | Difference of cardiovascular disease prevalence and target organ damage between patient who do or do not measure home blood pressure
Composites of cardiovascular disease: number of participants with non-fatal myocardial infarction, angina pectoris, revascularization of arteries, stroke, transient ischemic attack, atrial fibrillation, heart failure hospitalization, progression to end-stage renal failure or elevation of creatinine more than 2-fold, other undefined cardiovascular events at the discretion of the investigator Target organ damage: left ventricular hypertrophy by electrocardiography, brachial-ankle pulse wave velocity, microalbuminuria |
at baseline and 3 years of follow up | |
Secondary | Changes of home blood pressure measurement rate | Changes of home blood pressure measurement rate in study population after 3 year of follow up from baseline | from baseline to 3 years of follow up | |
Secondary | Cardiovascular disease events and target organ damage | Difference of occurrence of cardiovascular disease events and target organ damage between patient who measure and do not measure home blood pressure
Composites of cardiovascular disease events: number of participants with first occurrence of non-fatal myocardial infarction, angina pectoris, revascularization of arteries, stroke, transient ischemic attack, atrial fibrillation, heart failure hospitalization, progression to end-stage renal failure or elevation of creatinine more than 2-fold, other undefined cardiovascular events at the discretion of the investigator Target organ damage: left ventricular hypertrophy by electrocardiography, brachial-ankle pulse wave velocity, microalbuminuria from enrollment |
during 3 years of follow up from baseline measurement |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |